- Home
- TK vs KROS Comparison
TK vs KROS Comparison
Compare TK & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TK
- KROS
- Stock Information
- Founded
- TK 1973
- KROS 2015
- Country
- TK Bermuda
- KROS United States
- Employees
- TK N/A
- KROS N/A
- Industry
- TK Marine Transportation
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- TK Consumer Discretionary
- KROS Health Care
- Exchange
- TK Nasdaq
- KROS Nasdaq
- Market Cap
- TK 701.1M
- KROS 565.0M
- IPO Year
- TK 1995
- KROS 2020
- Fundamental
- Price
- TK $7.44
- KROS $13.73
- Analyst Decision
- TK
- KROS Buy
- Analyst Count
- TK 0
- KROS 14
- Target Price
- TK N/A
- KROS $20.56
- AVG Volume (30 Days)
- TK 661.9K
- KROS 413.0K
- Earning Date
- TK 07-30-2025
- KROS 08-06-2025
- Dividend Yield
- TK 26.92%
- KROS N/A
- EPS Growth
- TK N/A
- KROS N/A
- EPS
- TK 0.88
- KROS 0.47
- Revenue
- TK $992,518,000.00
- KROS $232,844,000.00
- Revenue This Year
- TK N/A
- KROS $5,390.70
- Revenue Next Year
- TK N/A
- KROS N/A
- P/E Ratio
- TK $8.59
- KROS $29.37
- Revenue Growth
- TK N/A
- KROS 85820.30
- 52 Week Low
- TK $5.65
- KROS $9.12
- 52 Week High
- TK $9.78
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- TK 43.37
- KROS 43.50
- Support Level
- TK $7.12
- KROS $13.13
- Resistance Level
- TK $7.84
- KROS $14.75
- Average True Range (ATR)
- TK 0.22
- KROS 0.49
- MACD
- TK 0.03
- KROS -0.09
- Stochastic Oscillator
- TK 43.15
- KROS 34.96
About TK Teekay Corporation
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.